Earnings releaseEnglish
2025 Annual Results: Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma
The file is served by the AMF. We do not host a copy.
Next publication
Half-year financial report · H1
announced in this filingDocument type
- Issuer
- Fermentalg
- Filed
- 02/04/2026, 18:00
- Document type
- Earnings release
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 078981_20260402